cd38 inhibitor and 5-amino-1mq synergy nad+ Inhibition of enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism CD38 is a key mediator
CD38 is a key mediator of NAD+ depletion in the brain of ZIKV infected mice: iScience The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC CD38 connects the heart and brain Translational Psychiatry CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome PMC Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5





